NMPA Approval

Cefodizime Sodium for Injection and Sodium Chloride Injection

Approval Number

国药准字H20193158

Company北京锐业制药有限公司

Registration Date

May 28, 2024

Drug Information

Generic Name

注射用头孢地嗪钠/氯化钠注射液

Dosage Form

注射剂

Strength

粉体室：按头孢地嗪（C₂₀H₂₀N₆O₇S₄）计2.0g；液体室：氯化钠注射液40ml：0.36g

Drug Type

化学药品

Registration Date

May 28, 2024

Company Information

Applicant Company

Company Name北京锐业制药有限公司

Company Address

北京市北京经济技术开发区隆庆街12号

Manufacturing Company

Company Name北京锐业制药（潜山）有限公司

Company Address

安徽省潜山市皖国东路0012号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用头孢地嗪钠/氯化钠注射液 - NMPA 批准文号 | MedPath